medications for atrial fibrillation - HEALTHY
Tyler Morning Telegraph: Christus Health among first for trial treatment of atrial fibrillation Milwaukee Journal Sentinel: NovaRhythm Obtains Global Rights from Sanofi for SAR-297871 to Advance Precision Atrial Fibrillation Therapy NovaRhythm Obtains Global Rights from Sanofi for SAR-297871 to Advance Precision Atrial Fibrillation Therapy Atrial fibrillation treatment with device closure matched anticoagulants and reduced bleeding risk. Discover what this means for AF care. CBS News: Results from University of Miami study could one day change how people with atrial fibrillation are treated Miller School of Medicine could one day change the way people with atrial fibrillation are treated.
Context Explanation
Researchers at UM conducted the Liraglutide Effects in Atrial Fibrillation (LEAF) study starting in ... Results from University of Miami study could one day change how people with atrial fibrillation are treated Medical Xpress: Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in patients with device-detected atrial fibrillation. Today, the findings were ... Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation WebMD: Anticoagulation for Ongoing Stroke Prevention in Adults With Atrial Fibrillation (Afib) Atrial fibrillation, or AFib, is a type of irregular heart rhythm that causes your heart to pump less effectively than it should.
Image Collection
Insight Material
You’ll get treatment to try to bring back a normal rhythm. Another ... The American Journal of Managed Care: Unmet Needs in the Management of Atrial Fibrillation Experts discuss the persistent clinical and systemic challenges in diagnosing and treating atrial fibrillation, emphasizing the need for earlier identification—especially in high-risk, comorbid ...